1 The findings showed: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) As a retrospective analysis, this study has limitations including potential confounding factors, and definitive randomised controlled trials are needed to confirm any disease-modifying effects of GLP-1 medications in MS
Discontinuation protocols When discontinuation becomes necessary, whether due to side effects, cost, pregnancy planning, or personal preference, abrupt cessation causes rapid weight regain in most individuals
JULIA: Hola, Laura
Like most research peptides, retatrutide is sensitive to heat, light, repeated freeze-thaw cycles, and prolonged exposure at ambient temperatures
PT-141 was originally discovered as a side effect during research on melanotan II, a synthetic tanning peptide